CYNATA THERAPEUTICS LIMITED
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Further CYP-001 GvHD Clinical Data Published in Nature Medicine 2024-05-23 07:53
Patient Enrolment Completed in CYP-006TK Diabetic Foot Ulcer Clinical Trial 2024-04-08 08:47
First Patient Treated in Phase 2 GvHD Trial 2024-03-05 10:08
Encouraging Initial Data from CYP-006TK Diabetic Foot Ulcer Clinical Trial 2024-02-26 14:37
LUMC to Fund New Clinical Trial of Cynata's Cymerus™ MSCs in Kidney Transplantation 2022-11-04 09:15
US FDA Clears IND for Cynata's Phase 2 Clinical Trial of CYP-001 in GvHD 2022-05-26 20:44
Cynata Enters into a New Strategic Partnership with Fujifilm 2021-09-30 21:30
1